Evidence map›Paper›PMID 29961128›Full record

ArticleMikrochimica acta2018

Fluorometric aptamer-based determination of ochratoxin A based on the use of graphene oxide and RNase H-aided amplification.

Changbei Ma, Kefeng Wu, Han Zhao, Haisheng Liu, Kemin Wang, Kun Xia

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Changbei MaSchool of Life Sciences, Central South University, Changsha, 410013, China. macb2012@csu.edu.cn.
Kefeng WuSchool of Life Sciences, Central South University, Changsha, 410013, China.
Han ZhaoSchool of Life Sciences, Central South University, Changsha, 410013, China.
Haisheng LiuSchool of Life Sciences, Central South University, Changsha, 410013, China.
Kemin WangState Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, 410081, China.
Kun XiaSchool of Life Sciences, Central South University, Changsha, 410013, China. xiakun@sklmg.edu.cn.
Central South University · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors describe a fluorometric assay for ochratoxin A (OTA) that is based on the use of graphene oxide and RNase H-aided amplification. On addition of OTA, cAPT is replaced from the APT/cAPT hybridization complex and then hybridizes with RNA labeled with a fluorophore at the 5'-end. Eventually, the fluorophore is released by RNase H cleavage. As the concentration of OTA increases, more cAPTs are displaced, this leading to fluorescence enhancement (best measured at excitation/emission wavelengths of 495/515 nm). This RNase H-assisted cycle response results in strong signal amplification. The limit of detection, calculated on the basis of a signal to noise ratio of 3, is 0.08 ng·mL

Indexed as

Nucleic Acid Amplification TechniquesAptamers, NucleotideBase SequenceBiosensing TechniquesFluorometryGraphiteOchratoxinsOxidesRibonuclease HWineAptamers, NucleotideGraphiteochratoxin AOchratoxinsOxidesRibonuclease HFluorescence assayMycotoxinNanomaterialsRed wineRNA probe

Identifiers

PMID29961128
OpenAlexW2810825256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.